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We recorded via telemetry the arterial blood pressure (BP) and heart rate (HR) response
to classical conditioning following the spontaneous onset of autoimmune diabetes in
BBDP/Wor rats vs. age-matched, diabetes-resistant control (BBDR/Wor) rats. Our purpose
was to evaluate the autonomic regulatory responses to an acute stress in a diabetic state
of up to 12months duration. The stress was a 15-s pulsed tone (CS+) followed by a 0.5-s
tail shock.The initial, transient increase in BP (i.e., the “ﬁrst component,” or C1), known to
be derived from an orienting response and produced by a sympathetic increase in periph-
eral resistance, was similar in diabetic and control rats through ∼9months of diabetes;
it was smaller in diabetic rats 10months after diabetes onset. Weakening of the C1 BP
increase in rats that were diabetic for >10months is consistent with the effects of sym-
pathetic neuropathy. A longer-latency, smaller, but sustained “second component” (C2)
conditional increase in BP, that is acquired as a rat learns the association between CS+
and the shock, and which results from an increase in cardiac output, was smaller in the dia-
betic vs. control rats starting from the ﬁrst month of diabetes. A concomitant HR slowing
was also smaller in diabetic rats.The difference in the C2 BP increase, as observed already
during the ﬁrst month of diabetes, is probably secondary to the effects of hyperglycemia
upon myocardial metabolism and contractile function, but it may also result from effects
on cognition. The small HR slowing concomitant with the C2 pressor event is probably
secondary to differences in baroreﬂex activation or function, though parasympathetic dys-
function may contribute later in the duration of diabetes.The nearly immediate deﬁcit after
disease onset in the C2 response indicates that diabetes alters BP and HR responses to
external challenges prior to the development of structural changes in the vasculature or
autonomic nerves.
Keywords: cardiovascular system, autonomic nervous system, dysautonomia, Pavlovian (classical) conditioning,
anxiety, telemetry
INTRODUCTION
The autonomic nervous control of the cardiovascular function
can be profoundly altered from normal in diabetes. A quanti-
tative analysis of the changes in the expression of autonomically
mediated changes in cardiovascular function, evoked in a precisely
controlled manner in the experimental animal, would contribute
meaningfully to our understanding of the implications of this per-
vasive disease in man. Classical aversive conditioning has proven
to be an effective tool to study the autonomic regulation of car-
diovascular function in a variety of rat strains (e.g., Randall et al.,
1993, 1994; Li et al., 1997; Brown et al., 1999). This is partic-
ularly true because we know a great deal about the autonomic
nervousmediation of the conditional cardiovascular response and
the hemodynamic underpinnings of the changes in mean arterial
blood pressure (mBP) and heart rate (HR). In particular, we have
reported (Randall et al., 1994) that classical aversive condition-
ing elicits stereotypic changes in autonomic nervous activity in rat
that, in turn, drive patterned changes (Randall et al., 1993, 1994) in
mBP, HR, stroke volume (SV), cardiac output (CO), and periph-
eral resistance (Li et al., 1998). The 24-h averagemBP andHR, and
mBP power spectra across∼9months duration of type 1 diabetes
have been described elsewhere (Anigbogu et al., submitted). The
objective of the present study is to probe the progressive effects of
diabetes overmanyweeks upon the cardiovascular response to this
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acute behavioral challenge in a rodentmodel of spontaneous-onset
diabetes (BBDP/Wor rat) vs. age-matched controls (BBDR/Wor
rat).We interpret the observed progressive effects of diabetes upon
the conditional response in terms of our knowledge of the neural
mediation of the response, and, where applicable, in terms of
diabetic autonomic neuropathy as previously described in these
animals (Vinik et al., 2003).
MATERIALS AND METHODS
ANIMALS
A total of 12 diabetes prone (BBDP/Wor; hereafter the “BB rat”)
and 12 diabetes-resistant age-matched controls (BBDR/Wor; here-
after “control”) rats were used in one or more stages of this
study. All animals were obtained from the Biomedical Models
Inc. (Rutland, MA, USA). The diabetes-prone rats spontaneously
develop an autoimmune, abrupt onset Type 1 diabetes melli-
tus between 50 and 120 days of age characterized by polydip-
sia, polyuria, and hyperglycemia (Chappel and Chappel, 1983).
The study was approved by the University of Kentucky Ani-
mal Care and Use Committee. The rats were obtained from the
vendor at 31–45 days of age. The animals were housed in an
isolated, sound shielded, limited access room where the temper-
ature was controlled at 72˚F/22˚C, 56% humidity, and a 12/12-h
light/dark cycle. The rats were fed on standard rat chow (Har-
lan Teklad 2018, Madison, WI, USA) and had access to water
ad libitum.
The BB animals were weighed each morning, including week-
ends, and blood glucose was measured in a drop of blood from the
saphenous vein using the One-Touch Ultra glucometer (LifeScan
Inc., Milpitas, CA, USA). The control animals were weighed each
Friday, and their plasma glucose determined, also from prick of
the saphenous vein.
The day the animal ﬁrst showed a morning blood glucose level
above 250mg/dl was taken as onset of diabetes mellitus and des-
ignated “Day 0.” The diabetes duration, in days, was calculated
from this time. The diabetic rats were maintained on an insulin
dose schedule developed by the breeder to manage blood glucose
levels appropriately. This involved giving protamine–zinc insulin
(PZI) 0.9U/100 g/day, subcutaneously. The dose was increased or
reduced by 0.2 units/day, depending on weight gain or loss and
plasma glucose level.
SURGERY
All surgery was performed under anesthesia (sodium pentobar-
bital; 65mg/kg, IP) with procedures appropriate for rodent sur-
vival surgery. The average age at surgery was 61 days (range:
43–89 days). The abdominal aorta was accessed via a laparotomy.
The sensory element of a Data Sciences International (DSI) probe
(model TA11PA-C40) was placed into the aorta via a puncture.
The catheter containing the sensitive element of the probe was
secured in place with surgical glue. The body of the probe that
contains the sensor, transmitter, and battery was secured to the
interior abdominal wall with sutures. The incision was closed and
the rat monitored until it aroused from the anesthetic. The animal
was returned to the home cage once it had aroused and was self
grooming. Rats were allowed a minimum of 10 days recuperation
before any cardiovascular data were used.
BEHAVIORAL CONDITIONING
The classical conditioning paradigm has been described in detail
elsewhere (Randall et al., 1993, 1994). Brieﬂy, the animals were
habituated for 1–2 h daily for several days to handling and restraint
in a comfortable cloth sock. Each rat was then exposed daily to
ﬁve trials of a 15-s pulsed tone (CS+) and another ﬁve trials of
a steady tone (i.e., non-pulsed; CS−) that was identical in pitch
and intensity to the pulsed-sound. CS+ and CS− were presented
in pseudorandom pairs (e.g., . . .CS−, CS+, CS+, CS−,. . .). On
this initial training day only the last (i.e., ﬁfth) pulsed tone was
reinforced with the 0.5-s tail shock (i.e., the unconditional stim-
ulus, US); the US shock was delivered via bipolar electrodes held
by a plastic cuff placed around the subject’s tail prior to each day’s
trials. The US was adjusted to the lowest value that caused the rat
to ﬂinch and squeak which was usually 0.2mA and never exceeded
0.3mA. Training continued for two additional days during which
each CS+was shock reinforced. Aminimum of 5min was allowed
between presentations of successive trials to allow the studied vari-
ables to return to baseline. Each rat was removed from the sock
at the end of each daily session and was returned to the animal
quarters.
Once trained, each animal’s conditional response was elicited
every 2weeks. An initial set of ﬁve CS+ and ﬁveCS− trials was run
to “refresh” the conditional response; the next day a second set of
ﬁve CS+ and ﬁve CS− trials was run, data were recorded and ana-
lyzed for this set. Subjects were started in the paradigm at different
times during the course of their diabetes to probe function starting
at the onset (i.e., starting within a day or two of conversion) and
extending through 1 year of the diabetic state. Since animals died
or implants failed during the course of the study, the total number
of potential subjects changed over time. To eliminate the effects
upon the average values for any variable of any given animal’s
dropping out of the data set three “cadres” were identiﬁed, each
of which contained a ﬁxed set of animals across a speciﬁed time
post-conversion. Cadre 1 included four diabetic and four control
rats that provided a complete set of data for months 1–3 after the
diabetic animals’conversions. These animalswere sock habituated,
trained in the paradigm and conditioning sessions started at, or
immediately after, their conversion to thediabetic state to assess the
responses before any“structural”effects of diabetes could bemani-
fest. Cadre 2 included six diabetic and eight control rats whose data
set remained intact from months 4–9; their training, etc., started
at ca. 3–9weeks post-conversion. Finally, Cadre 3 included three
diabetic and six control subjects, each of which provided condi-
tioning data for months 10 through 12; their behavioral training
started at ca. 15weeks post-conversion. Some rats participated in
more than one cadre.
DATA ACQUISITION AND ANALYSIS
The arterial BP telemetry data were obtained during the condi-
tioning trials using the PhysioTel RPC 1 receiver. The received
signal was fed into a DSI Data Exchange Matrix to which was con-
nected an ambient pressure reference (APR 1). The output from
the matrix was sent via a Dataquest PCI card into the Pentium IV
computer based workstation running a Dataquest A.R.T system
software program. The output from this computer was cross fed
into an analog output Data Exchange Matrix. The analog output
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of the DEM was passed through a BNC-2110 A–D converter
(National Instruments) into an analysis and output computer for
further processing or display. The data were analyzed using an in-
house developed computer program (ViiSoftware, Lexington, KY,
USA) running on a Pentium IV based computer. HR was com-
puted from the pulsatile blood pressure signal. Each “trial” started
15 s before tone onset and extended for 15 s after shock delivery.
For any given animal, for any given daily set of CS+ trials (and
for CS− trials), a “high resolution analysis” of the conditional
mBP and HR response was constructed by computerized “ensem-
ble averaging” the ﬁve individual trials (Randall et al., 1993, 1994).
Again, for any given animal the individual high resolution tri-
als were ensemble averaged for month 1, for month 2, etc. [see
Figure 4 for an example taken from month 6 for a control (black)
and diabetic (red) animal].
The baseline mBP (and HR) was assessed by a beat-by-beat
average during the 15-s prior to tone onset for each monthly
ensemble, as immediately above, for each rat. The conditional
response was assessed in each rat in terms of the initial peak mBP
change (relative to baseline) following tone onset (referred to as
the C1 pressor response), the change in mBP averaged across the
last 10 s of the tone (the C2 pressor response) and the correspond-
ing change in HR (the C2 bradycardia), and the change in mBP
relative to baseline over the ∼15 s interval immediately follow-
ing shock delivery (see Figure 1). The latency from tone onset
to the time at which the peak C1 pressor response was achieved
(tpeak) was also determined. Each of the aforementioned values
was determined for both CS+ and CS− trials. The ability to dis-
criminate between the “neutral” CS− and shock-reinforced CS+
is best assessed by the relative lack of change in mBP during C2 in
response to CS− as compared to the response during CS+ (Ran-
dall et al., 1994); this was indexed by the ratio of the (C2 change
in mBP during CS−)/(C2 change in mBP during CS+). A ratio
of 1 indicates no discrimination between conditions, whereas a
ratio of 0 indicates perfect discrimination. Data are presented as
mean± SD. Two-factor mixed analysis of variance (ANOVA) was
applied to the strainswith repeatedmeasures across time (months)
within a given cadre. One way within-subjects ANOVA for each
cadrewas used to test for changes across time (months) for the dia-
betic rats, or for the control rats, with appropriate post hoc tests.
Signiﬁcance was taken as p < 0.05.
RESULTS
BASELINE PLASMA GLUCOSE, BP, AND HR IN DIABETIC AND CONTROL
RATS
Plasma glucose concentrations averaged 112± 18mg/dl over all
diabetes-prone rats as measured at 7 days before their con-
version to the diabetic state. The corresponding value for the
diabetes-resistant animals was 97± 18mg/dl (NS). The Cadre 1
diabetic animals, for example, averaged 335± 18, 387± 22, and
415± 26mg/dl for months 1, 2, and 3 after their conversion,
respectively; the corresponding values for the age-matched resis-
tant rats in Cadre 1 were 99± 1, 101± 2, and 100± 1mg/dl.
Table 1 summarizes baseline mBP and HR for each month
post-conversion for which conditioning data are reported (see
below). ANOVAs within each cohort found no between group
differences for mBP, but revealed a signiﬁcant decline in mBP
FIGURE 1 | High resolution analysis (see text) showing change (;
relative to initial 15 s baseline) in mean arterial blood pressure (mBP;
top) and in heart rate (HR; bottom) classically conditioned to 15 s CS+
tone (dark bar, abscissa) followed by 1/2 s tail shock or to 15 s CS−
tone never followed by shock in Cadre 1 Control rats. Each tracing is an
ensemble average of conditional responses computed from non-diabetic
control rats (n=4) for month 1 (i.e., corresponding in time to ﬁrst month
after the age-matched diabetic rats “converted” to diabetes). The mBP
response to CS+ consists of an initial, short-latency pressor component
(C1) followed by a sustained “second component” (C2) increase; the period
over which C2 is assessed for analytical purposes is indicated in the ﬁgure.
The US evokes a very sharp mBP increase (truncated here), temporally
coincident with the rat’s ﬂinching in response to shock, followed by
rounded “hump” elevation in mBP. CS− also evokes a C1, presumably
because the rat is unable to determine instantaneously whether the tone is
pulsed (i.e., CS+) or steady (i.e., CS−). The failure of CS− to evoke C2
demonstrates that the rats discriminated between the two tones. The
major HR response to CS+ is a bradycardia coincident with C2; CS− does
not evoke a concomitant slowing, again indicating discrimination. The
unconditional HR response (i.e., to the US) is a tachycardia. Young control
rats demonstrate a clear conditional mBP and HR response and
discriminate between CS+ and CS−.
across months 4–9 (cohort 2: F5,60 = 2.95) and months 10–12
(cohort 3: F2,14 = 4.33); there were no signiﬁcant group (resis-
tant, diabetic) by time (months post-conversion) interactions.
There was a signiﬁcant between group difference in HR for all
three cohorts (cohort 1: F1,6 = 6.10; cohort 2: F1,12 = 7.23; cohort
3: F1,7 = 6.77), but no cohort showed a change over time or a
group× time interaction.
BLOOD PRESSURE AND HEART RATE CHANGES DURING CS+ AND CS−
IN CONTROL VS. DIABETIC SUBJECTS
CS+ vs. CS− response in control rats during month 1
Figure 1 illustrates the conditional change (; vs. baseline) inmBP
(top panel) and HR (bottom panel) in response to CS+ and CS−
averaged over the four control rats of Cohort 1 during month 1
(i.e., trials for the age-matched controls during the ﬁrst 30 days
that their BB partners were diabetic). To create this ﬁgure each of
the four rat’s conditional response for mBP and for HR was deter-
mined separately by averaging the ∼25 CS+ trials (and 25 CS−
trials) given to that animal over the month to construct a “high
resolution analysis.” These four individual high resolution ﬁles
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Table 1 | Baseline average mean arterial pressure and heart rate (±SD)
at designated times pre- and post-conversion for diabetic and
age-matched control rats.
Control Diabetic
mBP (mm Hg) HR (bpm) mBP (mm Hg) HR (bpm)
CADRE 1
Mo 1 120±8 383±15 114±12 382±41
Mo 2 123±9 382±12* 117±9 339±28
Mo 3 118±12 373±15 114±6 334±28
CADRE 2
Mo 4 119±9 368±32 112±8 353±31
Mo 5 115±11 383±27 111±13 356±30
Mo 6 114±16 399±18* 108±8 352±28
Mo 7 112±13 385±22* 110±10 354±27
Mo 8 112±6 368±22 109±8 349±20
Mo 9 111±9 380±21* 105±4 330±44
CADRE 3
Mo 10 112±10 395±26* 104±8 334±20
Mo 11 105±9 372±36 106±3 328±32
Mo 12 103±14 354±27 100±7 338±35
*=p<0.05, diabetic vs. control HR.
were then averaged to create the composites shown in the ﬁgure;
that is, all statistical analyses of these data are based upon an “n”
of 4 for each group. ThemBP response to CS+ includes the initial,
short-latency pressor response, C1, followed by the sustained C2
mBP increase. The period over which mBP and HR changes were
measured to quantify C2 (i.e., last 10 s of the tone) is indicated.
Note the substantial C2 HR slowing during CS+. The changes in
mBP and inHR concomitant with shock delivery and immediately
thereafter constitute the unconditional response (UR). The typi-
cal topography of the unconditionalmBP response in the controls,
as is seen here, consists of a sharp, very brief increase associated
with delivery of the shock itself (shown truncated in this ﬁgure),
followed immediately by a transient, rounded“hump” in pressure,
and then a rapid decline in mBP toward baseline. There were, of
course, no such changes at the end of CS− (i.e., when no US was
ever delivered). Finally, the failure of mBP andHR to demonstrate
sustained changes during CS− tone presentation demonstrates
that the rats discriminated between the two tones (Randall et al.,
1993, 1994).
CS+ response in diabetic vs. control rats during months 1–3
Figure 2 is similar in construction to Figure 1 except it com-
pares the response to CS+ alone in non-diabetic control rats
(n = 4; here, and hereafter, shown in black) and in diabetic rats
(n = 4; here, and hereafter, shown in red) during the ﬁrst 30 days
after the latter converted to the diabetic state (i.e., month 1).
The inserts show the group average± SD changes in mBP (top
panel) for peak mBP increase during C1 (C1 pk; top panel, left),
average mBP change during C2 (C2; top panel, center) and aver-
age mBP change during the recovery phase (post-US; top panel,
right). The single insert in the bottom panel shows the group
average change (i.e., slowing) in HR during C2. Both diabetic
FIGURE 2 | High resolution analysis showing change (, as in Figure 1)
in mean arterial blood pressure (mBP; top) and in heart rate (HR;
bottom) for CS+ trials in non-diabetic control rats (n=4; black) and in
diabetic rats (n=4; red) in response to CS+ tone (dark bar, abscissa)
presented in trials conducted during the ﬁrst 30days after the latter
converted to the diabetic state (i.e., month 1).The inserts show the
group average±SD changes vs. baseline in mBP and in HR for peak
increase during C1 (C1 pk, left-most insert), average change during C2
(middle insert) and average change during the recovery phase (post-US,
right insert). Average amplitude of C1 was similar in control and diabetic rats
at 1month. In rats that were in their ﬁrst month of diabetes there was no
C2 mBP increase, and, on the average, HR slowing (insert, lower panel) was
smaller in diabetic vs. control subjects. The “hump” in mBP that normally
(i.e., control state) follows immediately after tail shock was replaced by a
clear drop in pressure in the diabetic animals. The presence of the C1 mBP
increase in the diabetic rats suggests that a “sudden burst” in sympathetic
nerve activity normally evoked by CS+ also occurs in the diabetic animals
and yields an increase in peripheral resistance characteristic of the
conditional response pattern (see text). The failure of the diabetic animals to
show a C2 mBP increase is consistent with known effects of diabetes upon
myocardial metabolism and contractile function (see text), or with a deﬁcit
in cognitive function.
and control groups showed generally equal C1 pressor responses
(diabetic: +2.9± 3.6mm Hg; resistant: 2.2± 1.6mm Hg), but
the C2 and post-US increases in mBP were effectively absent in
the BB animals (C2: −0.4± 0.8mm Hg; post-US: −0.5± 2.3mm
Hg) as compared to the controls (C2: +7.0± 4.1mm Hg; post-
US: +3.2± 3.0mm Hg). Likewise, HR slowed markedly during
C2 (bottom panel, center) in the control animals (−24± 6 bpm),
with signiﬁcantly less slowing in the diabetics (−9± 10 bpm). The
latency from tone onset to the peak C1 pressor response, tpeak, in
the controls averaged across months 1, 2, and 3 was 1.4± 0.4 s.
The corresponding average for the diabetic animals was similar
(i.e., 1.5± 0.4 s). Similar differences in the various components of
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the response were seen throughout each of the ﬁrst 3months of
the study (see below).
The CS− tone evokes a C1 mBP component (Randall et al.,
1993, 1994), but no sustained cardiovascular change; the peak
amplitude of this response to CS− was not different in resis-
tant (month 1: +2.8± 1.2mm Hg; month 2: +4.1± 4.7mm Hg;
month 3: +2.8± 1.3mm Hg) vs. Cadre 1 diabetic rats (month
1: +1.1± 1.0mm Hg; month 2: 1.5± 2.4mm Hg; month 3:
2.4± 2.6mmHg).Theprimarypractical purpose forCS− is to test
the rat’s discrimination between CS+ and CS−. The discrimina-
tion ratios formonths 1, 2, and 3were 0.09± 0.15, 0.29± 0.32, and
0.00± 0.14, respectively for the controls.Discrimination could not
be reliably assessed for the BB animals given the small mBP during
C2 even for CS+.
Table 2 abandons, for the moment, the cadre classiﬁcation and
documents baselinemBP andHR, and the various changes inmBP
and HR, as given above, for each key component of the behav-
ioral response for all diabetic (n = 10) and all control (n = 11) rats
tested during month 3. Baseline mBP and HR were signiﬁcantly
(Student’s t ) lower between these larger groups of BB vs. control
rats, but, as in Cadre 1, the amplitude of the peakmBPC1 increase,
and the time to peak increase,were similar across groups. Likewise,
the amplitude of the C2 pressor response was large in the control
animals, but virtually absent in the diabetic subjects, though the
concomitant HR decreases were small, and similar in size. There
was no between group difference in the post-US mBP response.
CS+ response in diabetic vs. control rats during months 4–9
Like Cadre 1, the peak increase in mBP for C1 for Cadre 2
rats averaged over 4–9months diabetes duration was similar
for the matched control (+ 3.5± 1.3mm Hg) and diabetic rats
(+ 2.6± 0.8mm Hg; NS) and neither group showed a trend to
change the magnitude of the response across time. As was illus-
trated above, the C2 component of the conditional cardiovascular
response is particularly telling. Figure 3 shows the group average
change± SD in mBP and in HR during C2 across Cadre 2 rats for
months 4–9. By month 4 the diabetic animals had developed a
modest C2 mBP increase (+ 2.2± 2.2mmHg) and a concomitant
HR decrease (−14.2± 9.1 bpm). The amplitude of the increase
in mBP was smaller in diabetic vs. control (F1,12 = 5.93), as was
Table 2 | Average±SD baseline mean arterial pressure and heart rate,
and changes vs. baseline in pressure and heart rate for key
components of conditional response in control and diabetic rats
tested at 3months diabetes duration.
Control (n =11) Diabetic (n =10)
Baseline mBP (mm Hg) 120±9 109±11*
Baseline HR (bpm) 365±24 339±30*
C1 pk mBP +3.8±4.3 +2.4±3.1
tpeak (s) 1.4±0.8 1.8±0.9
C2 mBP (mm Hg) +10.6±4.1 +0.8±2.1*
C2 HR (bpm) −13±22 −12±10
Post-US (mm Hg) +2.4±2.8 +1.0±3.2
*=p<0.05, Control vs. Diabetic.
FIGURE 3 | Average±SD change (vs. baseline) in mBP (top) and in HR
(bottom) during C2. Conditional changes in mBP and HR are evident, but
both were consistently smaller in diabetic (red) vs. control (black) rats for
trials conducted during months 4–9.
the HR slowing (F1,12 = 5.48). Figure 4 gives a more dynamic
impression of the rats’ responses during this stage of the develop-
ment of diabetes by showing the conditional responses to CS+ of
a diabetic animal at 6months compared to an age-matched con-
trol; the inserts show group averages during month 6. The clear,
but relatively smaller C2 component of the mBP response in the
diabetic animal vs. its control partner is evident. Moreover, the
concomitant HR slowing in the control animal manifests as very
modest acceleration in this particular diabetic rat. Note also that
the post-US change in BP vs. baseline in the controls was decid-
edly different (F1,10 = 7.85) vs. the diabetic rat(s); indeed, mBP
fell below baseline in the seconds immediately following shock
delivery in the BB animals, but rose, at least transiently, in the
controls. The average latency from tone onset to the peak C1 pres-
sor component (1.5± 0.4 s) did not change across the 6-months
in controls. It tended to increase across months in the BB ani-
mals from the shortest latency of 1.3± 1.2 s at 5months to the
longest latency of 3.3± 1.5 s at 8months, though the trend toward
increasing latency did not attain signiﬁcance (F5,20 = 1.8), nor did
the 6-month average of 1.9± 0.7 s for the BB differ signiﬁcantly
from that of the controls (1.7± 0.3 s). The peak mBP C1 response
to CS− was similar in resistant (6month average: +3.1± 1.0mm
Hg) and diabetic rats (6month average:+1.7± 1.4mmHg). Both
groups discriminated between CS+ and CS− (control index over
the 6-months= 0.17± 0.38; diabetic=−0.01± 0.63; NS).
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FIGURE 4 | High resolution analysis of changes in mBP (top) and in HR
(bottom) in a diabetic rat (red) from Cadre 2 for trials conducted during
the sixth month after it converted and corollary analysis for an
age-matched control (black). Inserts are group averages as in Figure 2.
Both groups showed similar peak C1 increases in mBP, and clear C2
changes in mBP, but the magnitude of the latter was smaller in diabetic vs.
control animals. This animal showed a small tendency for HR to increase
during C2, but as a group the diabetic animals at 6months of duration
showed a moderate bradycardia. As in Figure 2, mBP dropped after shock
delivery in the diabetic subjects.
CS+ response in diabetic vs. control rats during months 10–12
Cadre 3 consisted of six control animals and three diabetic rats
that were maintained through months 10–12. Figure 5 illus-
trates these differences for one diabetic and a matched control
for trials conducted during the 11th month of diabetes; the
inserts are computed, as above, across the rats of Cadre 3 for
month 11. In contrast to the conditional responses for both
groups shown in Figure 2, the diabetic rats had lost the initial
C1 mBP pressor response at this later phase in the develop-
ment of diabetic pathophysiology (upper left insert, Figure 5),
though, given the small “n” for the BB animals, this between
group difference fell short of signiﬁcance (CS+: F1,18 = 3.97;
CS−: F1,18 = 1.49). Likewise, the magnitude of the C2 bradycar-
dia tended to be smaller in the diabetic animals (Figure 5, lower
panel), but again failed of statistical signiﬁcance (F1,7 = 3.79). As
with Cadre 2, however, the post-US mBP increased above base-
line in the control animals and decreased in the BB animals
(F1,7 = 10.15).
HR/mBP in diabetic vs. control rats during months 10–12
There were no differences between the control and diabetic rats
in the ratio of the change in HR to the change in mBP dur-
ing C2 for CS+ trials through month 8. For rats in Cadre 3,
FIGURE 5 | High resolution analysis of changes in mBP (top) and in HR
(bottom) in a diabetic rat (red) from Cadre 3 for trials conducted during
the 11th month after it converted and corollary analysis for an
age-matched control (black). Inserts are group averages as in Figures 2
and 4. The C1 mBP increase was not evoked by presentation of CS+ in the
diabetic rat, and the C2 pressor event and concomitant HR slowing were
small in the diabetic vs. control. Mean arterial BP dropped after shock
delivery in the diabetic subjects. The lack of a C1 pressor response is
consistent with the development of diabetic sympathetic dysfunction by
∼1 year of disease duration.
however, the ratio was positive for the diabetic rats for months
10 (10.1± 12.6 bpm/mm Hg), 11 (16.0± 28.0 bpm/mm Hg), 12
(1.7± 5.9 bpm/mm Hg). The same ratio was negative for the
controls (n = 6) for months 10 (−10.3± 9.1 bpm/mm Hg), 11
(−13.0± 38.2 bpm/mm Hg), and 12 (−4.9± 33.4 bpm/mm Hg).
The between group difference was signiﬁcant (F1,7 = 13.3).
DISCUSSION
The major ﬁndings of this study as relates to diabetes are: (1)
during the ﬁrst months after conversion the amplitude of C1 was
similar in both the control and diabetic rats, but C1 diminished
in the BB subjects relative to the controls after the former had
been diabetic for ≥10months; (2) the smaller (than the C1 mBP
increase), but sustained C2 increase in mBP was either absent
(Cadre 1) or smaller (Cadre 2) in the diabetic as compared to
the control animals; (3) the C2 HR slowing was smaller in the dia-
betic animals vs. controls; (4) mBP fell relative to baseline during
the post-US interval in the BB animals vs. an increase in control
rats; (5) the latency to the initial peak C1 mBP increase tended to
increase progressively with time in the diabetic animals; (6) the
ratio of HR/mBP was positive in diabetic and negative in con-
trol subjects starting in month 10; (7) both groups discriminated
betweenCS+ andCS− (tested frommonth 4onward). Thediscus-
sion below suggests explanations for these observations in terms of
the hemodynamics underlying the conditional response and what
is known about the autonomic nervous control of the response
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pattern, and speculates about the mechanisms underlying these
effects.
THE SHORT-LATENCY CONDITIONAL PRESSOR RESPONSE (C1)
The initial pressor response, which we call C1, is preceded by
a large-amplitude, but short-lived “sudden burst” (SB) in sym-
pathetic nerve activity (SNA) in Sprague-Dawley rats (Randall
et al., 1994); the amplitude of the SB predicts the amplitude of the
C1 pressor response (Burgess et al., 1997). Immediately following
the SB the SNA decreases momentarily below baseline (the “quiet
period”); this drop in SNAprecedes a decline inmBP from thepeak
C1 value (Randall et al., 1994), and is probably attributable to the
action of the baroreﬂex (Willingham et al., 2004). In the Sprague-
Dawley the C1 BP increase is produced by an increase in peripheral
resistance, there being little-or-no concomitant change in either SV
or HR and, thereby, none in CO (Li et al., 1998). C1 originates as
an“inherent”orienting or startle response (though it subsequently
attains properties of a conditional response); that is, no “learning”
is required for the animal to demonstrate this component of the
response (El-Wazir et al., 2005). The similarity of the amplitude of
C1 in both the control and diabetic rats of Cadre 1 indicates that
the amplitudes of the SB in SNA were similar in both groups, and
that the sympathetic innervation of vascular smoothmuscle in the
newly diabetic rats retained the ability to elicit vasoconstriction.
Cadre 2 animals were followed serially from the fourth to ninth
months after the diabetic rats’ conversion to the diabetic state; this
is a period over which incipient, but progressive, deterioration in
autonomic function has been described in the diabetic BB rat (see
below). TheC1 pressor response continued to be preserved in both
groups, again suggesting the sympathetic control of vasomotor
function was intact, despite the progressively prolonging diabetic
condition. The latency (from tone onset) to attainment of the peak
C1 mBP increase tended to increase progressively across time in
these rats, perhaps indicating that the sympathetic nervous medi-
ation of the peripheral resistance increase was becoming more
“sluggish”with longer diabetes duration or that structural changes
in the vascular bed altered the response to sympathetic activity.
Finally, the C1 pressor response was no longer evident in those
rats studied during the 10th to 12th month of diabetes; this dif-
ference approached statistical signiﬁcance, but failed presumably
because of the small “n” for the diabetic group. This observation
suggests either that the SB in SNA was no longer evoked by the
CS+ tone, or that, if present, it no longer evoked an increase in
peripheral resistance. Either possibility is tenable given the known
diabetic dysautonomia by this time (e.g., Vinik et al., 2003).
THE C2 PRESSOR RESPONSE
One of the more remarkable observations was the absence (Cadre
1) or decreased magnitude (Cadre 2) in the diabetic animals vs.
controls of the C2 pressor and HR components of the conditional
response.We reported previously that the C2 pressor event, which
occurs following the SB in SNA and the subsequent “quiet period,”
is accompanied in time by a modest (ca. +24%), but sustained
increase in sympathetic activity (Randall et al., 1994). Relative to
baseline, peripheral resistance during C2 decreases on the average
by 4± 2 dyn·s/cm5 while CO increases by 2± 1ml/min (Li et al.,
1998). The sustained C2 mBP increase is dependent, therefore,
upon the heart’s developing and maintaining an increase in CO
over baseline. In contrast to C1, C2 is acquired as the animal learns
the association between the CS+ tone and the US shock (El-Wazir
et al., 2005) – the rat must learn the paradigm to display a C2.
Three explanations for these observations in our BB subjects
seem possible. The ﬁrst is that cognitive function was depressed
in the young diabetic rats so that they were unable to learn the
association between the CS+ tone and US shock, or that it took
longer to learn the association so that, by 4months Cadre 2, for
example, did display a small C2. Diabetes is, in fact, associated
with cognitive decrements, particularly during the period of brain
development in childhood and during aging (e.g., Biessels et al.,
2008). The BB rat shows signiﬁcantly prolonged latencies in the
Morris water maze test at 8months after onset of diabetes, but not
at 2months (Li et al., 2002). Given the latter observation, it seems
unlikely that a failure of the young animals in Cadre 1 to learn
the association between CS+ and the shock explains the missing
C2, though we cannot dismiss this potential explanation. The sec-
ond possibility is that the diabetic state limits the ability of the
heart to elevate CO in response to the increased SNA during C2.
Again, diabetes and/or hyperglycemia is known to be associated
with an early deﬁcit in myocardial diastolic relaxation which pro-
gresses with time to combined diastolic and systolic dysfunction
(reviewed in Sack, 2009). By 4weeks after administration of strep-
tozotocin to Sprague-Dawley rats the slower beta myosin heavy
chain content in small, but multicellular, myocardial preparations
increased from 34± 15% in control hearts to 100% in the diabetic
(Mitov et al., 2009) These changes in composition were associated
with functional changes in the elastic properties of the prepara-
tions, and support the hypothesis that pathological changes in
the mechanical properties of diabetic hearts are primarily attrib-
utable to alterations in the cycling cross-bridge contributions to
ventricular stiffness (Mitov et al., 2009). Such changes might, in
turn, be functionally related to alterations in myocardial metabo-
lism resultant from diabetes (reviewed in Taegtmeyer et al., 2002;
Young et al., 2002). Finally, it is possible that diabetic sympathetic
neuropathy has alreadymanifest itself so that the failure of mBP to
increase during C2 is because SNA failed to increase. For reasons
discussed below, this latter possibility seems unlikely for Cadre 1.
THE C2 BRADYCARDIA
Themodest C2 mBP increase seen in the diabetic animals in Cadre
2 was coincident with a deﬁnite, concomitant HR slowing, though
the magnitude of this bradycardia was small relative to that seen
in the age-matched controls. The C2 bradycardia is eliminated
by atropine, but only modestly (though signiﬁcantly) attenuated
by beta-adrenergic blockade in lean Zucker rat (El-Wazir et al.,
2008). The HR slowing is therefore attributable primarily to ele-
vated parasympathetic nervous drive to the SA-node. One viable
explanation, therefore, for the modest C2 bradycardia is an incip-
ient dysfunction of these nerves. This possibility is attractive in
light of the actual tachycardia seen in the diabetic rat in Figure 4.
Nonetheless, a second possibility for the smaller C2 bradycar-
dia is the diminished concomitant pressor event, which, in turn,
would occasion a more modest activation of the baroreﬂex and
less HR slowing. Finally, it could be that the baroreﬂex itself was
becoming dysfunctional in the diabetic animals at ≥9months.
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The HR/mBP computation based upon the corresponding C2
data is an index of baroreﬂex function, but only if one assumes
that there is little-or-no “central control” component to the slow-
ing. While the latter assumption seems somewhat problematic,
the ﬁndings in this regard are interesting. That is, the fact that
this ratio was positive for the diabetic animals, but was negative
for the controls, as expected for a functioning reﬂex, supports
the ﬁnal explanation, above. We have published a more speciﬁc
preliminary analysis of baroreﬂex function in the rats at >1 year
diabetic duration (Burgess et al., 2009). In the ﬁnal analysis, all
three mechanisms, above, may well contribute to the small C2 HR
slowing.
POST-US ARTERIAL BLOOD PRESSURE CHANGES
One additional and striking difference between the control and
diabetic animals was manifest essentially in each Cadre of BB ani-
mals: the post-US increase in mBP normally seen at ∼32 s (i.e.,
immediately after the sharp spike coincident with actual delivery
of the shock) was replaced by a drop in mBP (e.g., Figure 4, upper
right insert). CO drops from its elevated value during C2 immedi-
ately followingUSdelivery (Li et al., 1998), so this transient pressor
event is attributable to a short-lived increase in peripheral resis-
tance. Given that the diabetic state reportedly (e.g., Agrawal et al.,
1987; Xie et al., 2010) is associated with vascular smooth muscle
hypercontractility, and our belief that the rat’s ability to elevate
peripheral resistance remains intact, at least through ∼9months
of diabetes, these ﬁndings suggest that CO drops even more pro-
foundly in the BB animals after US delivery than it does in the
control animals. This would be consistent with our hypothesized
inability of the diabetic animals to increase CO normally during
C2. However, the possibility of a reduced vasodilator function,
and a shift toward vasoconstriction in diabetic animals during the
baseline condition, could also produce a reduced reserve capacity
for further increase in vascular resistance and thereby in BP.
DIABETIC AUTONOMIC NEUROPATHY
Autonomic and sensory neuropathies have been described in the
BB rat. Alterations in nerve collagens can be detected by 4months
(Wang et al., 2003). Nerve conduction velocity slows progressively
over time, declining by 17% at 14months (Sima et al., 2000). At 4
and 8months the BBDP/Wor show a progressive redistribution of
nodal Na+ channels across the paranodal and internodal regions
that are associated with the conduction slowing (Cherian et al.,
1996). Axonal dystrophic changes in sympathetic ﬁbers, which
are the hallmark of autonomic neuropathy in human diabetics,
are consistently evident in the BB rat after ca. 8months of dia-
betes (Yagihashi and Sima, 1985a; Schmidt et al., 2003). The main
structural abnormality consists of expanded axons containing a
variety of normal and abnormal subcellular structures, prompt-
ing the investigators to conclude that“dystrophic and degenerative
axonopathy is a reproducible structural hallmark of diabetic sym-
pathetic neuropathy” in the BB rat (Yagihashi and Sima, 1985b).
BB rats diabetic for 28weeks reportedly have a 57% loss relative
to controls in ventricular myocardial sympathetic nerve ﬁbers and
varicosities and, in atrial tissue, a 42% loss in sympathetic axon
proﬁles containing varicosities (Addicks et al., 1993). Likewise,
comparisons of parasympathetic nerves from the diabetic BB rat
with non-diabetic, age-matched controls revealed abnormalities
in the former including increased numbers of axonal glycogeno-
somes, axonal sequestration, and diminished ﬁber size (Yagihashi
and Sima, 1986). Similar pathological changes have been described
in sensorynerves in theBB rat (Yagihashi et al., 1989), including the
carotid sinus nerve (Salgado et al., 2001). These ﬁndings are con-
sistent with our suggestions, above, that the loss of the C1 pressor
response by ∼10months, is primarily attributable to sympathetic
neuropathy.
CONCLUSION
This study examined in a rat model of Type 1 diabetes the changes
inmBP andHR performance and autonomic cardiovascular regu-
latory and reﬂex functions in a chronic andmanaged diabetic state
across the ﬁrst year of the disease process. The nearly immediate
expression of deﬁcits after disease onset in the C2 component of
the conditional response normally elicited by CS+ demonstrates
that the disease alters mBP and HR control much earlier than one
could expect there to be any structural changes in the vasculature
or autonomic nerves. While it is possible that this results from
effects of hyperglycemia on cognition, it seems more reasonable
in light of available data to attribute these early consequences to
effects on myocardial function and metabolism. These ultimately
impact the ability of the heart to elevate CO in response to acute
challenges. Conversely, the diminution of the C1 event as the dura-
tion of the disease approaches 1 year is consonant with what is
known about the progression of diabetic dysautonomia.
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APPENDIX
Control rats
Month # →
Bo =Cn Cadre 1 2 3 4 5 6 7 8 9 10 11 12
C-01 2 3 x x x x x x x x x
C-04 2 3 x x x x x x x x x x
C-11 x x x x x
C-22 2 x x x x x x x x
C-25 2 x x x x x x x x x x x
C-26 2 3 x x x x x x x x x x
C-27 2 3 x x x x x x x x x x
C-28 2 3 x x x x x x x x x x
C-59 1 x x x x x x x x
C-60 1 x x x x x x
C-61 1 2 x x x x x x x x x x
C-62 1 x x x x x x x x
Diabetic rats
R0 =Dn Cadre 1 2 3 4 5 6 7 8 9 10 11 12
D-02 2 3 x x x x x x x x x
D-11 x x
D-12 1 x x x x
D-22 2 x x x x x x x
D-24 x x x
D-39 2 3 x x x x x x x x x x x
D-40 2 3 x x x x x x x x x x
D-42 2 x x x x x x x x
D-59 1 2 x x x x x x x x x x
D-60 1 x x x x x x x
D-62 1 x x x x x
D-63 x x
x=Conditioning BP and HR data available.
Frontiers in Physiology | Integrative Physiology August 2011 | Volume 2 | Article 53 | 10
